Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Ahad Azimuddin is a surgical researcher whose work centers on the comparative effectiveness and health economics of robotic surgery, particularly in hepatobiliary and gastric oncology. His most influential study, “Robot-assisted liver resection: the real benefit so far” (2022, 21 citations), critically evaluates whether the technological advantages of robotic platforms translate into meaningful clinical improvements over traditional approaches. Dr. Azimuddin’s subsequent cost analyses—including a propensity score-matched study of robotic versus open hepatectomy (2024, 5 citations) and a detailed perioperative cost assessment of robotic gastrectomy (2024, 2 citations)—provide essential data for hospitals weighing the high implementation and maintenance costs of robotic systems against potential benefits. His work on the evaluation and recalibration of risk-stratified pancreatoduodenectomy drain fluid amylase removal criteria (2023, 2 citations) further demonstrates his commitment to refining postoperative management protocols. By combining rigorous economic modeling with clinical outcomes analysis, Dr. Azimuddin’s research helps surgeons and administrators make evidence-based decisions about adopting costly robotic technologies, ensuring that patient benefits justify the significant financial investments.